335 Results

People

  1. Pastores
    Pastores
  2. Brennan
    Brennan
  3. Sepkowitz
    Sepkowitz
  4. Horwitz
    Horwitz
  5. Dunkel
    Dunkel
  6. Heller
    Heller
  7. Herr
    Herr
  8. Kelsen
    Kelsen
  9. Zelenetz
    Zelenetz
  10. Abou-Alfa
    Abou-Alfa

Groups

  1. Department of Medicine (168)
  2. Hematologic Malignancies, Division of (78)
  3. Center for Hematologic Malignancies (74)
  4. Solid Tumor Oncology Division (74)
  5. Surgery (69)
  6. Survivorship Research (47)
  7. Anesthesiology and Critical Care Medicine (30)
  8. Adult Leukemia (28)
  9. Center for Pancreatic Cancer Research (28)
  10. Division of Subspecialty Medicine (27)
  1. "sepsis"
Formats
  1. Journal Article (305)
  2. Review (13)
  3. Editorial (5)
  4. Research Letter (4)
  5. Conference Paper (3)
  6. Correspondence (3)
  7. Guidelines (2)
Groups
  1. Department of Medicine (168)
  2. Hematologic Malignancies, Division of (78)
  3. Center for Hematologic Malignancies (74)
  4. Solid Tumor Oncology Division (74)
  5. Surgery (69)
  6. Survivorship Research (47)

More Groups

People
  1. Stephen Pastores (22)
  2. Murray Brennan (11)
  3. Kent Sepkowitz (9)
  4. Martin Tallman (9)
  5. Steven Horwitz (8)
  6. Andrew Zelenetz (7)

More People

Years
  1. 2025 (19)
  2. 2024 (26)
  3. 2023 (19)
  4. 2022 (12)
  5. 2021 (7)
  6. 2020 (24)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Cancer (15)
  3. Lancet Oncology (13)
  4. Leukemia and Lymphoma (12)
  5. Blood (11)
  6. Journal of Urology (8)

More Publications

Publishers
  1. Elsevier Science, Inc. (36)
  2. Elsevier Inc. (33)
  3. American Society of Clinical Oncology (24)
  4. Wiley Blackwell (22)
  5. Lippincott Williams & Wilkins (19)
  6. Nature Publishing Group (18)

More Publishers

Results (335)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: Interim results from a multicentre, open-label, phase 1b study
    Journal Article

    Sequist, L. V.; Han, J. Y.; Ahn, M. J.; Cho, B. C.; Yu, H.; Kim, S. W.; Yang, J. C. H.; Lee, J. S.; Su, W. C.; Kowalski, D.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Clonally-related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications
    Journal Article

    Kumar, P.; Uppal, M.; Xiao, W.; Dogan, A.; Roshal, M.; Gao, Q.; Aypar, U.; Zhang, Y.; Arcila, M. E.; Moung, C.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Outcomes of ICU admission of patients with progressive metastatic gastrointestinal cancer
    Journal Article

    Epstein, A. S.; Yang, A.; Colbert, L. E.; Voigt, L. P.; Meadows, J.; Goldberg, J. I.; Saltz, L. B.
    Journal of Intensive Care Medicine (2020)

    Fulltext@MSK | Save
  • Short-term safety and effectiveness of sugammadex for surgical patients with end-stage renal disease: A two-centre retrospective study
    Journal Article

    Adams, D. R.; Tollinche, L. E.; Yeoh, C. B.; Artman, J.; Mehta, M.; Phillips, D.; Fischer, G. W.; Quinlan, J. J.; Sakai, T.
    Anaesthesia (2020)

    Fulltext@MSK | Save
  • Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): A two-arm, randomised, open-label, phase 2 study
    Journal Article

    Lonial, S.; Lee, H. C.; Badros, A.; Trudel, S.; Nooka, A. K.; Chari, A.; Abdallah, A. O.; Callander, N.; Lendvai, N.; Sborov, D.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Acute kidney injury and CKD associated with hematopoietic stem cell transplantation
    Review

    DeMauro Renaghan, A.; Jaimes, E. A.; Malyszko, J.; Perazella, M. A.; Sprangers, B.; Rosner, M. H.
    Clinical Journal of the American Society of Nephrology (2020)

    Fulltext@MSK | Save
  • A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer
    Journal Article

    Moore, K. N.; Miller, A.; Bell-McGuinn, K. M.; Schilder, R. J.; Walker, J. L.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; Hagemann, A. R.; Gray, H. J.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy of vemurafenib in patients with non–small-cell lung cancer with BRAF V600 mutation: An open-label, single-arm cohort of the histology-independent VE-Basket study
    Journal Article

    Subbiah, V.; Gervais, R.; Riely, G.; Hollebecque, A.; Blay, J. Y.; Felip, E.; Schuler, M.; Gonçalves, A.; Italiano, A.; Keedy, V.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Adult Drosophila lack hematopoiesis but rely on a blood cell reservoir at the respiratory epithelia to relay infection signals to surrounding tissues
    Journal Article

    Sanchez Bosch, P.; Makhijani, K.; Herboso, L.; Gold, K. S.; Baginsky, R.; Woodcock, K. J.; Alexander, B.; Kukar, K.; Corcoran, S.; Jacobs, T.; more...
    Developmental Cell (2019)

    Fulltext@MSK | Save
  • Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/refractory B cell non-Hodgkin lymphoma
    Journal Article

    Jain, T.; Sauter, C. S.; Shah, G. L.; Maloy, M. A.; Chan, J.; Scordo, M.; Avecilla, S. T.; Batlevi, Y.; Dahi, P. B.; Batlevi, C. W.; more...
    Leukemia (2019)

    Fulltext@MSK | Save